CN Patent

CN105434333A — 美索舒利栓剂及其制备方法和用途

Assigned to Hubei Co Ltd Of Bio-Pharmaceutical Industry Institute For Research And Technology · Expires 2016-03-30 · 10y expired

What this patent protects

本发明提供了美索舒利栓剂及其制备方法和用途，所述美索舒利栓剂包括：美索舒利；以及药学上可以接受的辅料。本发明的美索舒利栓剂药物溶出度高，无刺激性，可起到很好的解热、镇痛、抗炎等作用，而且载药量大，给药次数少，使用简单，且价格便宜，经济实用，对于老人、儿童、或者不能口服的患者给药非常方便。

USPTO Abstract

本发明提供了美索舒利栓剂及其制备方法和用途，所述美索舒利栓剂包括：美索舒利；以及药学上可以接受的辅料。本发明的美索舒利栓剂药物溶出度高，无刺激性，可起到很好的解热、镇痛、抗炎等作用，而且载药量大，给药次数少，使用简单，且价格便宜，经济实用，对于老人、儿童、或者不能口服的患者给药非常方便。

Drugs covered by this patent

Patent Metadata

Patent number
CN105434333A
Jurisdiction
CN
Classification
—
Expires
2016-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Hubei Co Ltd Of Bio-Pharmaceutical Industry Institute For Research And Technology
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.